HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$46.44
Day range
$45.48 - $46.68
Year range
$13.72 - $48.32
Market cap
2.74B USD
Avg Volume
666.95K
P/E ratio
17.67
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 4.17M | — |
Operating expense | 42.96M | 1.43% |
Net income | -30.62M | 20.40% |
Net profit margin | -734.73 | — |
Earnings per share | -0.50 | 26.47% |
EBITDA | -38.55M | 8.46% |
Effective tax rate | 2.16% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 564.00M | 79.96% |
Total assets | 614.63M | 91.79% |
Total liabilities | 73.30M | 177.69% |
Total equity | 541.32M | — |
Shares outstanding | 58.90M | — |
Price to book | 5.04 | — |
Return on assets | -15.59% | — |
Return on capital | -17.42% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -30.62M | 20.40% |
Cash from operations | 268.62M | 1,123.79% |
Cash from investing | -88.12M | -442.05% |
Cash from financing | 2.57M | -97.62% |
Net change in cash | 183.08M | 69.99% |
Free cash flow | 285.68M | 2,345.18% |
About
Founded
2006
Headquarters
Website
Employees
125